Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06175000
Title Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Providence Health & Services
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Providence St. Vincent Medical Center RECRUITING Portland Oregon 97225 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field